Friday, September 24, 2021
HomeWORLDMODERNA ANNOUNCES START OF COVID-19 VACCINE TRIALS FOR CHILDREN

MODERNA ANNOUNCES START OF COVID-19 VACCINE TRIALS FOR CHILDREN

US manufacturer Moderna on Tuesday said it has started COVID-19 vaccine trials for children aged from six months to under 12 years old, with plans to enroll about 6,750 participants.

“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” said Chief Executive Officer  Stephane Bancel in a statement.

- Advertisement -

“This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population.”

US health authorities say that fewer children have been sick with COVID-19 compared to adults, but they can be infected and can spread the virus.

Most infected children have mild symptoms or no symptoms at all.

School officials across the US are under pressure to fully reopen as soon as possible, but many say they need portable classrooms or shorter school days to meet social distancing rules.

Moderna said 17.8 million adults in the United States have received its vaccine, as the country seeks to step up its inoculation program against the coronavirus pandemic that has killed over 535,000 people in America.

- Advertisement -spot_img
- Advertisement -

Most Popular

- Advertisement -
Advertisement

Get new posts by email

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Related News

You cannot copy content of this page